Heart-Targeted Nanoscale Drug Delivery Systems

被引:40
|
作者
Liu, Meifang [1 ]
Li, Minghui [1 ]
Wang, Guangtian [1 ]
Liu, Xiaoying [1 ]
Liu, Daming [1 ]
Peng, Haisheng [1 ,2 ]
Wang, Qun [2 ,3 ]
机构
[1] Harbin Med Univ, Dept Pharmaceut, Daqing 163319, Peoples R China
[2] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA
[3] Iowa State Univ, Dept Civil Construct & Environm Engn, Ames, IA 50011 USA
关键词
Heart-Targeted; Nanoscale; Materials; Drug Delivery Systems; Clinical Trials; TREATMENT-RESISTANT HYPERTENSION; ISCHEMIA-REPERFUSION INJURY; CERIUM OXIDE NANOPARTICLES; SOLID LIPID NANOPARTICLES; PRESSURE-RELATED DISEASE; ALPHA-D-MANNOPYRANOSIDE; IN-STENT RESTENOSIS; ACID MIXED MICELLES; GLYCOL BLEND FIBERS; NF-KAPPA-B;
D O I
10.1166/jbn.2014.1894
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The efficacious delivery of drugs to the heart is an important treatment strategy for various heart diseases. Nanocarriers have shown increasing promise in targeted drug delivery systems. The success of nanocarriers for delivering drugs to therapeutic sites in the heart mainly depends on specific target sites, appropriate drug delivery carriers and effective targeting ligands. Successful targeted drug delivery suggests the specific deposition of a drug in the heart with minimal effects on other organs after administration. This review discusses the pathological manifestations, pathogenesis, therapeutic limitations and new therapeutic advances in various heart diseases. In particular, we summarize the recent advances in heart-targeted nanoscale drug delivery systems, including dendrimers, liposomes, polymer-drug conjugates, microparticles, nanostents, nanoparticles, micelles and microbubbles. Current clinical trials, the commercial market and future perspective are further discussed in the conclusions.
引用
收藏
页码:2038 / 2062
页数:25
相关论文
共 50 条
  • [1] Albumin Nanoparticle Formulation for Heart-Targeted Drug Delivery: In Vivo Assessment of Congestive Heart Failure
    Lomis, Nikita
    Sarfaraz, Ziyab K.
    Alruwaih, Aiman
    Westfall, Susan
    Shum-Tim, Dominique
    Prakash, Satya
    [J]. PHARMACEUTICALS, 2021, 14 (07)
  • [2] Targeted nanoscale drug delivery systems for melanoma therapy
    Fan, Lanlan
    Wang, Zheng
    Shi, Dunyun
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 86
  • [3] Nanoscale drug delivery for targeted chemotherapy
    Xin, Yong
    Huang, Qian
    Tang, Jian-Qin
    Hou, Xiao-Yang
    Zhang, Pei
    Zhang, Long Zhen
    Jiang, Guan
    [J]. CANCER LETTERS, 2016, 379 (01) : 24 - 31
  • [4] Nanoscale Drug Delivery Systems in Glioblastoma
    Liu, Zihao
    Ji, Xiaoshuai
    He, Dong
    Zhang, Rui
    Liu, Qian
    Xin, Tao
    [J]. NANOSCALE RESEARCH LETTERS, 2022, 17 (01):
  • [5] Nanoscale systems for local drug delivery
    Ji, Tianjiao
    Kohane, Daniel S.
    [J]. NANO TODAY, 2019, 28
  • [6] Nanoscale Drug Delivery Systems in Glioblastoma
    Zihao Liu
    Xiaoshuai Ji
    Dong He
    Rui Zhang
    Qian Liu
    Tao Xin
    [J]. Nanoscale Research Letters, 17
  • [7] Targeted and triggered drug delivery systems
    Kohane, Daniel
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [8] Subcutaneous drug delivery from nanoscale systems
    Lorenzo Tomasini
    Marianne Ferrere
    Julien Nicolas
    [J]. Nature Reviews Bioengineering, 2024, 2 (6): : 501 - 520
  • [9] Functionalized nanoscale oil bodies for targeted delivery of a hydrophobic drug
    Chiang, Chung-Jen
    Lin, Che-Chin
    Lu, Tzu-Li
    Wang, Hesin-Fu
    [J]. NANOTECHNOLOGY, 2011, 22 (41)
  • [10] Organic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancer
    Shi, Meng
    Lu, Jiao
    Shoichet, Molly S.
    [J]. JOURNAL OF MATERIALS CHEMISTRY, 2009, 19 (31) : 5485 - 5498